2024
PO0205 Investigation of Inter-Observer Variability of Rectovaginal Reference Point Definition for Cervical Cancer Brachytherapy
Adefres B, Wallington D, Tien C, Damast S. PO0205 Investigation of Inter-Observer Variability of Rectovaginal Reference Point Definition for Cervical Cancer Brachytherapy. Brachytherapy 2024, 23: s96. DOI: 10.1016/j.brachy.2024.08.140.Peer-Reviewed Original ResearchExternal beam radiotherapyTreatment planning systemCervical cancer brachytherapyObserver 1Inter-observer variationObserver 2High dose rate brachytherapyDose gradientCombined external beam radiotherapyExternal beam radiotherapy doseDose measurementsPhysical doseCancer brachytherapyPosterior vaginal wallCervical cancer patientsBrachytherapy techniquesPlanning systemInter-observer differencesInter-observer variabilityBrachytherapy doseCumulative EQD2HDR-BTVaginal doseBeam radiotherapyVaginal wall
2023
PO38 Clinical Outcomes Following Brachytherapy for Endometrial Cancer Patients with Narrow Vaginal Anatomy
Adefres B, Tien C, Damast S. PO38 Clinical Outcomes Following Brachytherapy for Endometrial Cancer Patients with Narrow Vaginal Anatomy. Brachytherapy 2023, 22: s84-s85. DOI: 10.1016/j.brachy.2023.06.139.Peer-Reviewed Original ResearchVaginal cuff brachytherapyVaginal recurrenceEndometrial cancerEC patientsVaginal surfaceClinical outcomesVaginal anatomyGrade 2Single-channel vaginal cylinderStage IVb endometrial cancerAdjuvant vaginal cuff brachytherapyConsecutive EC patientsEndometrial cancer patientsExcellent local controlKaplan-Meier methodExternal beam radiotherapyInsertional painBaseline painVaginal stenosisCTCAE v4.0Patient demographicsStage IIIAUrinary toxicityMedian ageMedian BMI
2020
Stage III uterine serous carcinoma: modern trends in multimodality treatment
Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S. Stage III uterine serous carcinoma: modern trends in multimodality treatment. Journal Of Gynecologic Oncology 2020, 31: e53. PMID: 32266802, PMCID: PMC7286763, DOI: 10.3802/jgo.2020.31.e53.Peer-Reviewed Original ResearchConceptsUterine serous carcinomaExternal beam RTVaginal brachytherapyOverall survivalHuman epidermal growth factor receptorModern treatment eraSentinel node samplingRegional nodal recurrenceKaplan-Meier estimatesLog-rank testCox proportional hazardsExternal beam radiotherapyEpidermal growth factor receptorERA treatmentGrowth factor receptorUSC patientsFree survivalNodal recurrenceTreatment eraMultimodality treatmentPatient characteristicsPerioperative periodRegional nodalSerous carcinomaNode sampling